GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Change In Other Working Capital

Philogen SpA (STU:78Q) Change In Other Working Capital : €3.54 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Change In Other Working Capital?

Philogen SpA's Change In Other Working Capital for the quarter that ended in Jun. 2024 was €3.74 Mil. It means Philogen SpA's Other Working Capital increased by €3.74 Mil from Dec. 2023 to Jun. 2024 .

Philogen SpA's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €1.02 Mil. It means Philogen SpA's Other Working Capital increased by €1.02 Mil from Dec. 2022 to Dec. 2023 .


Philogen SpA Change In Other Working Capital Historical Data

The historical data trend for Philogen SpA's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Change In Other Working Capital Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
-2.59 -3.12 -6.03 1.02

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only -1.48 -4.56 1.22 -0.20 3.74

Philogen SpA Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Industry
Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines